Abstract
Here we show that transplantation of autologous human hematopoietic fetal liver CD34+ cells into NOD/SCID mice previously implanted with human fetal thymic and liver tissues results in long-term, systemic human T-cell homeostasis. In addition, these mice show systemic repopulation with human B cells, monocytes and macrophages, and dendritic cells (DCs). T cells in these mice generate human major histocompatibility complex class I– and class II–restricted adaptive immune responses to Epstein-Barr virus (EBV) infection and are activated by human DCs to mount a potent T-cell immune response to superantigens. Administration of the superantigen toxic shock syndrome toxin 1 (TSST-1) results in the specific systemic expansion of human Vβ2+ T cells, release of human proinflammatory cytokines and localized, specific activation and maturation of human CD11c+ dendritic cells. This represents the first demonstration of long-term systemic human T-cell reconstitution in vivo allowing for the manifestation of the differential response by human DCs to TSST-1.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts
Journal of Mammary Gland Biology and Neoplasia Open Access 13 June 2022
-
Latency reversal plus natural killer cells diminish HIV reservoir in vivo
Nature Communications Open Access 10 January 2022
-
Longitudinal clonal tracking in humanized mice reveals sustained polyclonal repopulation of gene-modified human-HSPC despite vector integration bias
Stem Cell Research & Therapy Open Access 07 October 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout





References
Greiner, D.L., Hesselton, R.A. & Shultz, L.D. SCID mouse models of human stem cell engraftment. Stem Cells 16, 166–177 (1998).
Bente, D.A., Melkus, M.W., Garcia, J.V. & Rico-Hesse, R. Dengue fever in humanized NOD/SCID mice. J. Virol. 79, 13797–13799 (2005).
Cravens, P.D. et al. Development and activation of human dendritic cells in vivo in a xenograft model of human hematopoiesis. Stem Cells 23, 264–278 (2005).
Palucka, A.K. et al. Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors. Blood 102, 3302–3310 (2003).
Islas-Ohlmayer, M. et al. Experimental infection of NOD/SCID mice reconstituted with human CD34+ cells with Epstein-Barr virus. J. Virol. 78, 13891–13900 (2004).
Aldrovandi, G.M. et al. The SCID-hu mouse as a model for HIV-1 infection. Nature 363, 732–736 (1993).
McCune, J.M. et al. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241, 1632–1639 (1988).
Vandekerckhove, B.A. et al. Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse. J. Immunol. 146, 4173–4179 (1991).
Akkina, R.K., Rosenblatt, J.D., Campbell, A.G., Chen, I.S. & Zack, J.A. Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. Blood 84, 1393–1398 (1994).
An, D.S. et al. High-efficiency transduction of human lymphoid progenitor cells and expression in differentiated T cells. J. Virol. 71, 1397–1404 (1997).
Roos, M.T. et al. Changes in the composition of circulating CD8+ T cell subsets during acute Epstein-Barr and human immunodeficiency virus infections in humans. J. Infect. Dis. 182, 451–458 (2000).
Dinges, M.M., Orwin, P.M. & Schlievert, P.M. Exotoxins of Staphylococcus aureus. Clin. Microbiol. Rev. 13, 16–34 (2000).
Makida, R., Hofer, M.F., Takase, K., Cambier, J.C. & Leung, D.Y. Bacterial superantigens induce Vβ-specific T cell receptor internalization. Mol. Immunol. 33, 891–900 (1996).
Kum, W.W., Cameron, S.B., Hung, R.W., Kalyan, S. & Chow, A.W. Temporal sequence and kinetics of proinflammatory and anti-inflammatory cytokine secretion induced by toxic shock syndrome toxin 1 in human peripheral blood mononuclear cells. Infect. Immun. 69, 7544–7549 (2001).
Karp, D.R., Teletski, C.L., Scholl, P., Geha, R. & Long, E.O. The α1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1. Nature 346, 474–476 (1990).
Traggiai, E. et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304, 104–107 (2004).
Gimeno, R. et al. Monitoring the effect of gene silencing by RNA interference in human CD34+ cells injected into newborn RAG2−/− γc−/− mice: functional inactivation of p53 in developing T cells. Blood 104, 3886–3893 (2004).
Ishikawa, F. et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice. Blood 106, 1565–1573 (2005).
Shultz, L.D. et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγnull mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174, 6477–6489 (2005).
Ito, M. et al. NOD/SCID/γcnull mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100, 3175–3182 (2002).
Yahata, T. et al. Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor γ null mice. J. Immunol. 169, 204–209 (2002).
Gatlin, J., Padgett, A., Melkus, M.W., Kelly, P.F. & Garcia, J.V. Long-term engraftment of nonobese diabetic/severe combined immunodeficient mice with human CD34+ cells transduced by a self-inactivating human immunodeficiency virus type 1 vector. Hum. Gene Ther. 12, 1079–1089 (2001).
Gatlin, J., Melkus, M.W., Padgett, A., Kelly, P.F. & Garcia, J.V. Engraftment of NOD/SCID mice with human CD34+ cells transduced by concentrated oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein. J. Virol. 75, 9995–9999 (2001).
Estes, J.D. et al. Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J. Infect. Dis. 193, 703–712 (2006).
Heslop, H.E. et al. Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nat. Med. 2, 551–555 (1996).
Acknowledgements
The authors thank M. Islas-Ohlmayer, P. Cravens, M.P. Martin, Z. Sun, A. Curry, S. O'Reilly and R. Getachew for their participation in this study, for the cytokine assay and for assistance with animal care. We thank J. Sixbey for the stock of Akata virus, A. Leen and C. Rooney for their assistance with the establishment of the LCLs and the ELISPOT analysis, K. Hamra and D. Garbers for use of their dissecting microscope and assistance collecting the ELISPOT images, M. Bennett, D. Douek, L. Picker, L. Schultz and J. McCune for their support and contribution to the early stages of this project, J. Tew and M. Kosco-Vilbois for advice and expert discussion regarding the organization of secondary lymphoid tissues, and D. Autry for graphic art assistance. Cord blood samples were provided by the Department of Obstetrics and Gynecology's Tissue Procurement Facility of the University of Texas Southwestern Medical Center at Dallas (US National Institutes of Health (NIH) grant HD011149). This work was supported in part by NIH grants R37 AI028246 (A.T.H.), CA82055 and AI39416 (J.V.G.) and training grants 5T32 AI005284 (P.W.D.) and T32 AI07421 (J.D.E.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
Immunohistological staining for human CD45+ cells and lineage-specific hematopoietic markers in BLT liver compared to human liver. (PDF 145 kb)
Supplementary Fig. 2
Analysis of EGFP expression in different hematopoietic cell subsets after transplantation with CD34+ cells transduced with a lentivirus-based vector. (PDF 100 kb)
Supplementary Fig. 3
Immunohistological analysis of secondary lymhoid tissues of BLT mice. (PDF 214 kb)
Supplementary Fig. 4
Spleen CD123+ human DCs do not respond to TSST-1. (PDF 65 kb)
Supplementary Table 1
Analysis of human CD4+ and CD8+ T cells in different tissues from BLT mice. (PDF 38 kb)
Supplementary Table 2
Naive versus memory phenotype of human peripheral blood T cells in BLT mice. (PDF 31 kb)
Rights and permissions
About this article
Cite this article
Melkus, M., Estes, J., Padgett-Thomas, A. et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 12, 1316–1322 (2006). https://doi.org/10.1038/nm1431
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm1431
This article is cited by
-
Humanized mouse models for immuno-oncology research
Nature Reviews Clinical Oncology (2023)
-
Latency reversal plus natural killer cells diminish HIV reservoir in vivo
Nature Communications (2022)
-
De novo construction of T cell compartment in humanized mice engrafted with iPSC-derived thymus organoids
Nature Methods (2022)
-
Use of lysates from pooled human mononuclear cells to activate CD3 T cells in humanized mice with low human cell engraftment efficiency
In Vitro Cellular & Developmental Biology - Animal (2022)
-
In Vivo Modeling of Human Breast Cancer Using Cell Line and Patient-Derived Xenografts
Journal of Mammary Gland Biology and Neoplasia (2022)